Two anxiety scales correlated and examined for sex differences

Sinick, Daniel

doi:10.1002/1097-4679(195610)12:4<394::aid-jclp2270120424>3.0.co;2-i

Cited by 16 publications

(9 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies of the Taylor Manifest Anxiety Scale (TMAS) using both college students and psychiatric patients have found that females tend to score higher than males (Taylor, 1953;Sinick, 1956;Goodstein & Goldberger, 1955;Lazowick, 1955;Jahnke, Cromell, & Moussette, 1964;Bendig, 1954). Goodstein & Goldberger (1955) attributed the higher female scores on the TMAS to a basic difference in anxiety level.…”

mentioning

confidence: 99%

Sex Differences in the Taylor Manifest Anxiety Scale

Quarter

Laxer

1969

J Educational Measurement

View full text Add to dashboard Cite

A study comparing the performance of males and females on the Taylor Manifest Anxiety Scale extended the previous findings of a differential response pattern for males and females to a Canadian high school population. An item analysis identified 12 of the 50 items as being responsible for the higher female scores. The scores for Canadian high school students in this study were found to fall midway between those of university students and those of psychiatric patients tested in previous studies.

show abstract

mentioning

confidence: 99%

Sex Differences in the Taylor Manifest Anxiety Scale

Quarter

Laxer

1969

J Educational Measurement

View full text Add to dashboard Cite

show abstract

“…Many investigators have used the MAS to study anxiety levels, and the results are evaluated by dividing them into five grades [4,5,26]. Male and female patients were graded separately because female patients tend to show high anxiety levels [5,26]. Grade I, which is more than 23 points for male and 26 points for female subjects, is considered a high anxiety level, and grade II, which is 19-22 for male and 22-25 for female subjects, is considered an anxiety level.…”

Section: Discussionmentioning

confidence: 53%

“…We evaluated the levels of anxiety by means of the MAS, which was developed by Taylor [28]. Many investigators have used the MAS to study anxiety levels, and the results are evaluated by dividing them into five grades [4,5,26]. Male and female patients were graded separately because female patients tend to show high anxiety levels [5,26].…”

Section: Discussionmentioning

confidence: 99%

Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer

Fujisawa

Ohno

Tokumaru

et al. 2001

Supportive Care in Cancer

View full text Add to dashboard Cite

The level of anxiety was examined before treatment by means of the Manifest Anxiety Scale (MAS) in 41 patients with squamous cell carcinoma of the head and neck. They received 5 days of neoadjuvant chemotherapy with cisplatin (CDDP) and 5-fluorouracil (5FU). Granisetron (KYT) was administered daily from day 1 to day 5. Nausea, vomiting, appetite, and well-being were assessed during and after chemotherapy. The relation between the effects of KYT and anxiety was studied. Seventeen patients were proven to have anxiety and were compared with the other 24 patients. In patients with anxiety, the percentage well-being was significantly lower on days 1 and 2 (P=0.008, 0.001). The rate of freedom from nausea was significantly lower from day 4 to day 9 for anxiety patients (P=0.010-0.050). The percentage of anxiety patients without loss of appetite was significantly lower from day 6 to 9 (p=0.001-0.020). The rate of freedom from vomiting was significantly lower on days 4, 5 and 7 for anxiety patients (P=0.024, 0.024, 0.014). The results indicate that the effect of KYT was significantly lower from day 3 to day 7 for anxiety patients (P=0.008-0.045). The anxiety group had significantly poorer well-being at the beginning of chemotherapy, and were not responsive to KYT in the delayed phase. Our results prove that anxiety patients show delayed emesis, and the administration of KYT is considered insufficient. It may be important to co-administer a tranquilizer to any patient who exhibit anxiety as defined by the MAS, in order to reduce delayed emesis.

show abstract

“…Sinick (115) compared mean male and female scores on the Sarason Test Anxiety Scale and the TMAS and computed correlations. Females made higher mean scores on both instruments and had greater variances.…”

Section: Development Of Anxiety Scalesmentioning

confidence: 99%